Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1???E2 Envelope Protein Complexes, The Journal of Experimental Medicine, vol.72, issue.5, pp.633-642, 2003. ,
DOI : 10.1093/emboj/21.12.2893
URL : https://hal.archives-ouvertes.fr/inserm-00133783
Neutralizing antibody response during acute and chronic hepatitis C virus infection, Proceedings of the National Academy of Sciences, vol.180, issue.4, pp.10149-10154, 2004. ,
DOI : 10.1086/314973
Inhibition of Hepatitis C Virus-Like Particle Binding to Target Cells by Antiviral Antibodies in Acute and Chronic Hepatitis C, Journal of Virology, vol.78, issue.17, pp.9030-9040, 2004. ,
DOI : 10.1128/JVI.78.17.9030-9040.2004
Pegylated interferon ? therapy in acute hepatitis C: Relation to hepatitis C virus-specific T cell response kinetics, Hepatology, vol.99, issue.6, pp.1721-1731, 2004. ,
DOI : 10.1002/hep.20266
Effects of antiviral therapy on the cellular immune response in acute hepatitis C, Hepatology, vol.179, issue.1, pp.87-97, 2004. ,
DOI : 10.1002/hep.20253
Intrinsic immunity: a front-line defense against viral attack, Nature Immunology, vol.78, issue.11, pp.1109-1115, 2004. ,
DOI : 10.1146/annurev.immunol.20.083001.084359
Retroviruses under editing crossfire, EMBO reports, vol.5, issue.7, pp.679-680, 2004. ,
DOI : 10.1128/JVI.78.11.6073-6076.2004
Human Apolipoprotein B mRNA-editing Enzyme-catalytic Polypeptide-like 3G (APOBEC3G) Is Incorporated into HIV-1 Virions through Interactions with Viral and Nonviral RNAs, Journal of Biological Chemistry, vol.279, issue.34, pp.35822-35828, 2004. ,
DOI : 10.1074/jbc.M405761200
Inhibition of Hepatitis B Virus Replication by APOBEC3G, Science, vol.303, issue.5665, p.1829, 2004. ,
DOI : 10.1126/science.1092066